Immunogenicity and Safety of GSK Biologicals' DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) (SB213503) in Healthy Indian Infants
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 12 May 2017
At a glance
- Drugs Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa) (Primary)
- Indications Diphtheria; Influenza B virus infections; Pertussis; Poliomyelitis; Tetanus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 08 May 2017 Planned End Date changed from 27 Apr 2018 to 30 Mar 2018.
- 08 May 2017 Planned primary completion date changed from 27 Apr 2018 to 30 Mar 2018.
- 28 Apr 2017 New trial record